MRUS - Merus GAAP EPS of -$0.59 beats by $0.20 revenue of $7.89M misses by $0.45M
2024-05-09 12:45:05 ET
More on Merus
- Merus: Positive Zenocutuzumab Data In 2024 Could Provide BLA Advancement
- FDA accepts Merus application for Zeno for lung, pancreatic cancer
- Gilead to invest in Merus as part of a research deal
- Seeking Alpha’s Quant Rating on Merus
- Historical earnings data for Merus